Lactobionic acid (LA), containing gluconic acid and a Gal moiety, has rapidly emerged as an alternative targeting molecule thanks to the selective cellular uptake capacity of hepatoma-targeting chemotherapy due to its ability to bind ASGP-R [98]. The gene discussed is ASGR1; the disease is hepatocellular carcinoma.